Ketamine for Rapid Sedation in Agitated Trauma Patients
For a severely injured, markedly agitated trauma patient requiring rapid sedation, administer ketamine 1-2 mg/kg IV over 60 seconds or 4-5 mg/kg IM, with continuous monitoring and immediate airway equipment available. Ketamine is particularly advantageous in this population due to its sympathomimetic properties that help maintain hemodynamic stability in hemorrhagic shock, rapid onset, and preservation of airway reflexes 1.
Dosing and Administration Routes
Intravenous Route (Preferred if IV access available)
- Initial dose: 1-2 mg/kg IV administered slowly over 60 seconds 1
- Produces sedation within 30 seconds
- Duration: 5-10 minutes of surgical anesthesia
- Critical safety point: Rapid IV administration causes respiratory depression and enhanced vasopressor response—always administer over at least 60 seconds 1
- The 100 mg/mL concentration must be diluted 1:1 with sterile water, normal saline, or D5W before IV administration 1
Intramuscular Route (When IV access unavailable)
- Dose: 4-5 mg/kg IM (FDA labeling suggests 6.5-13 mg/kg for anesthesia, but lower doses of 3-4 mg/kg are effective for agitation) 1, 2
- Onset: 3-4 minutes 1
- Duration: 12-25 minutes 1
- Prehospital studies demonstrate 96.9% achieve adequate sedation in median 5 minutes with IM ketamine 3
- Recent systematic review of 650 patients showed mean sedation time of 7.2 minutes with IM ketamine 4
Essential Monitoring Requirements
Ketamine must be administered by physicians experienced in airway management, with emergency airway equipment immediately available 1. This is non-negotiable per FDA labeling.
Required monitoring includes:
- Continuous vital signs monitoring
- Continuous pulse oximetry
- End-tidal CO2 monitoring when available 5
- Level of sedation assessment
- Airway patency observation
Critical Safety Considerations
Airway Management
While ketamine preserves laryngeal-pharyngeal reflexes better than other sedatives, vomiting and aspiration can still occur 1. The FDA label explicitly states ketamine is not recommended for patients who have not followed nil per os guidelines 1—however, in trauma this is universally the case, making vigilant airway monitoring essential.
Antisialagogue administration prior to ketamine is recommended due to hypersalivation risk (4.2-5.6% incidence) 1, 3.
Intubation Rates
A critical caveat: intubation rates vary dramatically by setting:
- Ground EMS transport: 30.5% intubation rate 4
- Emergency department use: 1.8% intubation rate 4
- Air medical transport: 4.9% intubation rate 4
The higher ground EMS intubation rate likely reflects arrival at the ED with ketamine still active, not necessarily ketamine-induced respiratory failure. When administered in the ED with appropriate monitoring, intubation rates are very low 4.
Hemodynamic Effects
Paradoxical finding: While ketamine has sympathomimetic properties theoretically beneficial in trauma, recent evidence shows increased hypotension episodes (RR 1.47) compared to other agents 6. This occurs because critically ill trauma patients have depleted catecholamine stores, and ketamine's direct myocardial depressant effects predominate 7.
Despite this, ketamine remains reasonable for RSI in trauma because:
- No mortality difference versus etomidate in trauma patients 7, 8
- Better than propofol's profound hypotensive effects 7
- Maintains better hemodynamics than most alternatives in hemorrhagic shock
Traumatic Brain Injury Considerations
Ketamine is safe in TBI patients—the historical concern about ICP elevation is outdated. Recent meta-analysis shows no significant ICP elevation in patients with baseline ICP <20 mmHg (RR 0.67, p=0.054) 6. No mortality difference exists between ketamine and other agents in TBI 6.
Rescue Dosing and Maintenance
If initial sedation inadequate:
- Repeat half to full induction dose as needed 1
- For prolonged sedation: continuous infusion at 0.1-0.5 mg/min (requires dilution to 1-2 mg/mL) 1
- 24.5% of agitated patients require rescue medications or additional doses 9
Adverse Effects Profile
Common adverse effects (generally self-limiting):
- Tachycardia: 5.1% 9
- Hypertension: 5.5-12.1% 9, 4
- Hypersalivation: 4.2-5.6% 9, 3
- Nausea: 2.1% 9
- Emergence reactions: 0.8-3.5% 9, 4, 3
- Transient hypoxia: 1.8-5.0% 4, 3
- Laryngospasm: 1.3% 4
Emergence reactions can be mitigated with benzodiazepine co-administration (e.g., midazolam 2-5 mg IV) 1, 2.
Alternative Agents When Ketamine Contraindicated
Etomidate
- Dose: 0.2-0.3 mg/kg IV
- Most hemodynamically stable alternative 7
- Concern for adrenal suppression, but single-dose use shows no mortality increase (OR 1.17) 7
- Comparable mortality to ketamine in trauma (19% each group) 7
Droperidol (for agitation without need for intubation)
- Preferred first-line for behavioral agitation when airway control not immediately needed 5
- Better safety profile than ketamine for pure agitation management 5
Avoid in Trauma
- Propofol: Most profound hypotensive effects, avoid in hemorrhagic shock 7
- Midazolam alone: Longer onset, potent venodilator, less suitable for RSI 7
Contraindications to Ketamine
Absolute contraindications:
- Conditions where significant blood pressure elevation would be hazardous (uncontrolled severe hypertension, acute coronary syndrome, aortic dissection)
- Severe coronary artery disease
- Known hypersensitivity
Relative contraindications requiring careful consideration: